The International Consortium for Personalised Medicine (ICPerMed) publishes a state-of-the-art report on an annual basis and seeks to facilitate the follow-up of the develop-ment of personalised medicine research and its implemen-tation throughout Europe and beyond. In this 2021 report, ICPerMed presents its activities (events, ICPerMed promotion videos, working group activities) of the past year 2021 and gives the stage to the ICPerMed Advisory Board to share their view on personalised medicine, the benefit personalised medicine can bring to healthcare, healthcare systems and for patients and citizens, as well as hurdles and important steps still to be taken to make per-sonalised medicine a reality for all.
STATE OF ART ICPerMed
CATERINA CINTI;MARIA GIOVANNA TRIVELLA;
2021
Abstract
The International Consortium for Personalised Medicine (ICPerMed) publishes a state-of-the-art report on an annual basis and seeks to facilitate the follow-up of the develop-ment of personalised medicine research and its implemen-tation throughout Europe and beyond. In this 2021 report, ICPerMed presents its activities (events, ICPerMed promotion videos, working group activities) of the past year 2021 and gives the stage to the ICPerMed Advisory Board to share their view on personalised medicine, the benefit personalised medicine can bring to healthcare, healthcare systems and for patients and citizens, as well as hurdles and important steps still to be taken to make per-sonalised medicine a reality for all.| File | Dimensione | Formato | |
|---|---|---|---|
|
prod_481008-doc_197679.pdf
solo utenti autorizzati
Descrizione: ICPerMed state of art report 2021
Licenza:
Altro tipo di licenza
Dimensione
767.72 kB
Formato
Adobe PDF
|
767.72 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
